Asset Planning,Inc Astrazeneca PLC Transaction History
Asset Planning,Inc
- $138 Billion
- Q3 2025
A detailed history of Asset Planning,Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Asset Planning,Inc holds 1,000 shares of AZN stock, worth $84,060. This represents 0.06% of its overall portfolio holdings.
Number of Shares
1,000
Previous 1,000
-0.0%
Holding current value
$84,060
Previous $69.9 Million
9.79%
% of portfolio
0.06%
Previous 0.05%
Shares
1 transactions
Others Institutions Holding AZN
# of Institutions
1,450Shares Held
498MCall Options Held
7.22MPut Options Held
2.57M-
Price T Rowe Associates Inc Baltimore, MD51.9MShares$4.37 Billion0.41% of portfolio
-
Primecap Management CO Pasadena, CA41.2MShares$3.46 Billion2.35% of portfolio
-
Wellington Management Group LLP Boston, MA34.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA31.4MShares$2.64 Billion0.39% of portfolio
-
Bank Of America Corp Charlotte, NC31.2MShares$2.62 Billion0.16% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $261B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...